Literature DB >> 19566874

Complete pathologic response after preoperative rectal cancer chemoradiotherapy.

Anthony Ciccocioppo1, Jacqueline H Stephens, Peter J Hewett, Nicholas A Rieger.   

Abstract

BACKGROUND: Following preoperative treatment of rectal cancer with chemoradiotherapy (CRT), a complete pathological response (CPR) can be seen in the surgical specimen. The aim of this study was to assess the outcome of these patients as compared with those who did not have a complete response.
METHODS: A retrospective study of the outcome of patients managed with preoperative CRT for their rectal cancer was conducted.
RESULTS: Between November 1998 and July 2004, there were 530 new presentations of rectal cancer at The Queen Elizabeth and Royal Adelaide hospitals. Forty of these patients (7.5%) were treated with long-course preoperative CRT. After resection, a CPR was seen in seven patients (17.5%). These patients were all disease free at January 2006 after a median follow-up of 6.0 years (range 1.42-7.02 years). One patient had died from non-tumour-/surgery-related causes. Tumour recurrence, but not mortality, in this group was superior to the comparison group of patients without a CPR.
CONCLUSIONS: None of our patients who had a CPR after preoperative CRT have recurred or died from their disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566874     DOI: 10.1111/j.1445-2197.2009.04950.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  8 in total

1.  Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer.

Authors:  Zhenbin Chen; Zheng Liu; Xutao Deng; Charles Warden; Wenyan Li; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2012-06       Impact factor: 4.585

2.  Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer.

Authors:  Zhenbin Chen; Zheng Liu; Wenyan Li; Kun Qu; Xutao Deng; Madhulika G Varma; Alessandro Fichera; Alessio Pigazzi; Julio Garcia-Aguilar
Journal:  Genes Chromosomes Cancer       Date:  2011-05-16       Impact factor: 5.006

3.  Paradigm shift in the management of rectal cancer.

Authors:  Nihit Rawat; Martyn D Evans
Journal:  Indian J Surg       Date:  2014-05-18       Impact factor: 0.656

4.  Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.

Authors:  Xiaoying Lou; Niyun Zhou; Lili Feng; Zhenhui Li; Yuqi Fang; Xinjuan Fan; Yihong Ling; Hailing Liu; Xuan Zou; Jing Wang; Junzhou Huang; Jingping Yun; Jianhua Yao; Yan Huang
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

5.  Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome.

Authors:  Mahshid Jalilian; Sidney Davis; Mohammadreza Mohebbi; Bhuvana Sugamaran; Ian W Porter; Stephen Bell; Satish K Warrier; Roger Wale
Journal:  J Gastrointest Oncol       Date:  2016-08

6.  Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.

Authors:  Haijie Lu; Qiqi Chu; Guojiang Xie; Hao Han; Zheng Chen; Benhua Xu; Zhicao Yue
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.

Authors:  Atthaphorn Trakarnsanga; Mithat Gönen; Jinru Shia; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Karyn A Goodman; Abraham Wu; Marc Gollub; Neil Segal; Leonard Saltz; Julio Garcia-Aguilar; Martin R Weiser
Journal:  J Natl Cancer Inst       Date:  2014-09-22       Impact factor: 13.506

Review 8.  Treatment of locally advanced rectal cancer: controversies and questions.

Authors:  Atthaphorn Trakarnsanga; Suthinee Ithimakin; Martin R Weiser
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.